Visual imagery to highlight content on this page

Trujillo Addresses Hispanic Chamber, Doctors

Roberto Trujillo at podium

Dr. Roberto Trujillo, president and chief executive of TruBios and an adjunct faculty member at Johns Hopkins University, told a group of Hispanic doctors and business leaders that biotechnology, creativity and education are critical to the success of the United States and Latin America.

“Biotechnology delivers breakthrough drugs and medical devices that save and improve the quality of people’s lives,” Trujillo said. “That is why it is imperative that countries invest in developing their biotechnology sector.”

Trujillo made his remarks during his keynote address at the Greater Washington Hispanic Chamber of Commerce’s annual gala. Hispanic doctors were honored at this event, which was sponsored, in part, by Johns Hopkins University’s Montgomery County Campus. Trujillo’s company, TruBios, is located on the Montgomery County Campus. He teaches for the Center for Biotechnology Education, which is part of the Krieger School of Arts and Sciences’ Advanced Academic Programs.

Trujillo talked about the four interrelated components of biotechnology: academia, technology, government and cooperative medicine. At universities, he said, the foundation of biotechnology is formed and dispersed to the medical community. Information is transferred to pharmaceutical and biotechnology companies, where new drugs and medical devices are developed. The government facilitates innovations through health policies aimed at preventing and curing disease. New developments are promoted in cooperative medicine.

Trujillo described the path he took in biotechnology, starting with his medical education in Mexico, his studies at Baylor College of Medicine in Texas, his clinical work and his research.

“Doing research was fulfilling,” Trujillo said. “I was very happy as a medical-scientist… but I felt on edge and powerless to help people dying of AIDS or young mothers dying of cancer.”

That feeling eventually led him to create biotech and clinical trial companies that offer life sciences products and services in Latin America.  His work now focuses on marketing a portable medical device that he says can cure lesions on the cervix before they become cancerous.

“This is an example of Hispanics curing Hispanic diseases,” Trujillo said. “This is our social responsibility. We need to fix our own problems and not expect other countries to fix them for us.”

He said he has come full circle, from medicine to science, to government and now to translational science.

“I am impatient,” he said. “I want to move science and technology faster. As a doctor in medicine and doctor in science, I feel the patient’s pain when they suffer from incurable diseases. Their pain empowers me to pursue novel solutions. I have hope, the hope to change the course of medicine.”


CATEGORY: Tenant News